Clinical trial

A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to…

NCT00000639 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00000639
Title A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
Official title A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Collaborators Washington University School of Medicine
Status Completed
Study type Interventional
Conditions Meningitis, Cryptococcal, HIV Infections
Intervention type Drug
Interventions Itraconazole, Flucytosine, Fluconazole, Amphotericin B
Enrollment 400
Completion Sep 1, 1997
First posted Aug 31, 2001
Last update posted Nov 2, 2021
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies